We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · February 22, 2021

Serum Alpha-Fetoprotein and Outcomes in Patients With Advanced HCC Treated With Ramucirumab

British Journal of Cancer


Additional Info

Disclosure statements are available on the authors' profiles:

British Journal of Cancer
Serum Alpha-Fetoprotein and Clinical Outcomes in Patients With Advanced Hepatocellular Carcinoma Treated With Ramucirumab
Br. J. Cancer 2021 Feb 03;[EPub Ahead of Print], AX Zhu, RS Finn, YK Kang, CJ Yen, PR Galle, JM Llovet, E Assenat, G Brandi, K Motomura, I Ohno, B Daniele, A Vogel, T Yamashita, CH Hsu, G Gerken, J Bilbruck, Y Hsu, K Liang, RC Widau, C Wang, P Abada, M Kudo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading